ADHD Trial, Recruiting (NCT06910605)

ADHD Trial, Recruiting NCT06910605 Sponsor: Stefan Lakämper Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT06910605 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who hold a driver's licence and drive regularly
People who have been diagnosed with ADHD and are treated with stimulant medication only (not other types of ADHD medication)
People who have a known history of taking planned breaks from their ADHD medication by their own choice (sometimes called "drug holidays")
People with significant eyesight correction needs of more than +/- 5 diopters, or who have astigmatism
People who are able to wear contact lenses during the study (required for the eye-tracking equipment used)

Who may not be able to join:

People who experience motion sickness, dizziness, or similar symptoms (this is checked during a 5-minute screening drive before the study)
People whose ADHD is managed with non-stimulant medications
People who are unable to understand the study procedures due to language barriers or cognitive difficulties
People who work as professional drivers during the period the study is taking place
Women who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stefan Lakämper, Dr. rer. nat., University of Zurich

Phone: +41793789984

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06910605

Sponsor: Stefan Lakämper

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: +41793789984

More information: https://clinicaltrials.gov/study/NCT06910605

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who hold a driver's licence and drive regularly
People who have been diagnosed with ADHD and are treated with stimulant medication only (not other types of ADHD medication)
People who have a known history of taking planned breaks from their ADHD medication by their own choice (sometimes called "drug holidays")
People with significant eyesight correction needs of more than +/- 5 diopters, or who have astigmatism
People who are able to wear contact lenses during the study (required for the eye-tracking equipment used)

Who may not be able to join:

People who experience motion sickness, dizziness, or similar symptoms (this is checked during a 5-minute screening drive before the study)
People whose ADHD is managed with non-stimulant medications
People who are unable to understand the study procedures due to language barriers or cognitive difficulties
People who work as professional drivers during the period the study is taking place
Women who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stefan Lakämper

Registry

ClinicalTrials.gov

Start date

2 June 2025

Est. completion

31 October 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Significant differences in IDS between conditions D and M

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov